Objectives Current evidence recommend Microarray testing as first-tier investigation for Children with developmental Delay and moderate to severe intellectual disability. Our aim is to see the ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.

Abstract: The paper describes a novel approach to the microarray image simulation in order to provide researchers with a tool for testing and evaluating the performance of analysis software.

Sometimes the rsID itself changed, sometimes the definition of what the chip microarray probe is delivering changed, and sometimes both. It is not clear if no calls are always delivered in that field ...

A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...

PathogenDx has introduced QuantX Bacterial, a novel four-in-one assay streamlining microbial testing compliance for cannabis laboratories across states. Headquartered in Scottsdale, Arizona, ...

NEW YORK – After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is poised to launch a microarray-based test for urinary tract infections later this year. The new ...